Form D · Biotechnology
MicroPure Genomics, Inc.
San Diego, CA · CIK 0002143996
Offering snapshot reported Jul 8, 2026 · SEC filing
- Reported sold
- $675K Offering amount: $2M
- Investors reported
- 11 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Apr 20, 2026 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jul 8, 2026 | Initial | $675,000 | No comparison | 11 | SEC filing |
Offering details
- Securities
- Option to acquire, Security to be acquired
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-589914
Source: Form D, filed Jul 8, 2026. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No matching detailed fund disclosure was found in the latest imported ADV filings. This does not establish that the issuer has no adviser.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Jason Butler | Director, Executive |
| Ryan Montes | Director, Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
5260 Fiore Terrace #I209
San Diego, CA, 92122
Phone: 813-748-8375
San Diego, CA, 92122
Phone: 813-748-8375